News
Global Cannabis News & Analysis | Business of Cannabis
News · page 28
- CBD Market
Google Warms To CBD, Kardashian’s German Ambitions, UN Softens Drugs Stance, Prohibitionists Pout, London Firm Looks To List in ‘Oz’
GOOGLE has made limited changes to its advertising policies to allow CBD topicals to be promoted on its platforms in three jurisdictions – California, Colorado, and Puerto Rico.
- Markets & Stocks
European Cannabis Stocks Review: Khiron Spikes On Colombian Insurance Deal, Apollon Divests Patents, & More From Seach Medical
Khiron Life Sciences INTERNATIONAL medical cannabis company Khiron has seen its share price skyrocket over 60% following a crucial resolution that was passed by the Colombian Ministry of Health.
- Companies
Apollon Formularies and Global Hemp Group sign Letter of Intent
UK-based Apollon Formularies and Global Hemp Group (GHG) have signed a Letter of Intent GHG will acquire the exclusive perpetual license for North America to certain Apollon Intellectual Property and proprietary technology.
- Medical
Italian Army Pledges To More Than Double Medical Cannabis Production This Year, But Supply Issues Far From Over
THE Italian army, which continues to hold a monopoly over medical cannabis production, has announced plans to dramatically ramp up production this year.
- CBD Market
UK company granted ethics approval for CBD trial
The company has received Ethics Approval from Bellberry Human Research Ethics Committee in Australia.
- Medical
Spain Misses Ambitious Medical Cannabis Roll Out Targets As Government Remains Tight-Lipped On Progress
SPAIN’s ambitious plans to see the regulation and distribution of medical cannabis rolled out across the country by the end of 2022 appear to have been delayed.
- CBD Market
Irish Court Prosecutions To Resume As Europe Ties Itself Up In CBD Knots
EUROPE’S flip-flopping over the status of CBD is allowing the Irish authorities free rein to persecute the country’s hemp and CBD industry, it has been claimed.
- Pharmaceutical
European Cannabis Stocks Review: Akanda Reports $2.3m Loss From Bophelo, OCT Shares Spike & Cellular Goods Sales Slow
Akanda Akanda unveiled its unaudited financial figures for the six months to the end of June 2022, two weeks after revealing that its CEO has been on ‘paid leave of absence’ since November.
- CBD Market
Big Win For French CBD Industry As Ban On Flowers Officially Scrapped, But Government Response Suggests Issue ‘Far From Over’
FRANCE’s highest court, the Council of State, has officially scrapped an attempted ban on the sale of CBD flowers and leaves.
- Adult-Use
What’s In Store For The European Cannabis Industry In 2023? (Part 2)
You can read Part 1 of our 2023 predictions here. Enexis AB According to the cannabis investment firm Enexis, economic pressures will mean capital available for the European cannabis industry will be ‘scarce’ in the first half of 2023; however, it predicts that this will begin to ‘rebound thereafter’.
- Adult-Use
What’s In Store For The European Cannabis Industry In 2023? (Part 1)
Following a milestone year for European cannabis in 2021, which saw many companies take advantage of a wave of excitement surrounding the young industry’s potential, 2022 saw this wave break sooner than many expected. 2023 is expected to bring yet more change.
- Adult-Use
Business<em>Cann</em>’s Top 10 Stories of 2022 – A Sticky Year For European Cannabis Ends On A High
TWELVE months ago we were recapping on what many were calling a break- through year for European cannabis following dramatic events in Germany with the new Government promising the continent’s first legalised adult-use market.
